Skip to content
2000
Volume 13, Issue 9
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Interleukin-1 receptor-associated kinase 4 (IRAK-4) plays a pivotal role in signaling cascades associated with the immune and inflammatory diseases. Regulation of IRAK-4 is an attractive approach to treating related diseases. Herein, ligand-based pharmacophore model and atom-based 3D-QSAR studies have been carried out on 92 known ATP competitive inhibitors to IRAK-4. Fourpoint pharmacophore hypotheses with one hydrogen acceptor (A), one hydrogen donor (D), and two aromatic rings (R) were developed by PHASE module of Schrödinger suit. The best pharmacophore hypothesis was selected on the basis of good PLS statistics (R2 train = 0.9806, Q2 test = 0.7182, Pearson-R = 0.8767, SD = 0.2248, RMSE=0.3152, F= 637.2). Furthermore, a series of virtual screening were performed and the Prime/MM-GBSA method based on the docking complex was used to predict the binding-free energy. Finally, 12 hits were identified as potent and novel IRAK-4 inhibitors. We mainly analyzed the binding modes and binding energies of the candidate compounds with the scaffolds of anthraquinones and 9-fluorenones. The result of virtual screening was further validated using molecular dynamics (MD) simulation analysis. A 10 ns MD simulation analysis revealed high stability and effective binding of ZINC09047206, ZINC12885209 within the active site of IRAK-4. It turned out that the anthraquinones hit ZINC09047206 and ZINC09477176 have more effective IRAK-4 inhibitory potential than those of other obtained hits.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180813666160421163027
2016-11-01
2025-07-06
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180813666160421163027
Loading

  • Article Type:
    Research Article
Keyword(s): 3D-QSAR; IRAK-4 inhibitors; MM-GBSA; molecular dynamics simulation; pharmacophore model
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test